{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T16:58:39Z","timestamp":1785430719691,"version":"3.56.0"},"reference-count":108,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical University of Gdansk","award":["02-0132\/07\/316"],"award-info":[{"award-number":["02-0132\/07\/316"]}]},{"award":["02-0132\/07\/316"],"award-info":[{"award-number":["02-0132\/07\/316"]}],"id":[{"id":"https:\/\/ror.org\/019sbgd69","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Background\/Objectives: Atherogenic dyslipidemia is a major cardiometabolic risk factor characterized by elevated circulating triglycerides (TGs), reduced HDL-C, and increased levels of atherogenic lipoproteins. Curcumin, a polyphenolic compound considered the main bioactive component of turmeric (Curcuma longa), has attracted growing interest because of its potential lipid-modifying and anti-inflammatory properties. This scoping review aimed to evaluate evidence from randomized controlled trials (RCTs) on the efficacy of curcumin supplementation in the management of atherogenic dyslipidemia and to summarize current mechanistic evidence related to curcumin absorption, metabolism, and regulation of lipid homeostasis. Methods: A PRISMA-ScR-guided scoping review was performed across five databases (PubMed, Scopus, Web of Science, Cochrane Library, and Embase). RCTs evaluating curcumin supplementation in atherogenic dyslipidemia or related cardiometabolic conditions were systematically identified and synthesized. Mechanistic and preclinical evidence was identified through separate topic-specific searches of PubMed, Scopus, and Web of Science, supplemented by citation searching, and was synthesized narratively. Results: Twenty-two RCTs published between 2008 and 2025 were included. Most studies involved patients with cardiometabolic disorders, including type 2 diabetes mellitus with hyperlipidemia, metabolic syndrome, and polycystic ovary syndrome. Curcumin supplementation, administered in various formulations and dosages, showed overall favorable effects on plasma lipid profiles, particularly TGs and LDL-C, although the magnitude of these effects varied across studies. Mechanistic and preclinical evidence suggested that curcumin may modulate multiple pathways involved in lipid homeostasis, including intestinal cholesterol uptake, hepatic lipogenesis, cholesterol synthesis, fatty acid oxidation, bile acid metabolism, and reverse cholesterol transport. Conclusions: Current evidence suggests that curcumin may improve atherogenic lipid profiles through pleiotropic effects on lipid metabolism and cholesterol homeostasis. The clinical efficacy of curcumin appears to depend substantially on formulation-related bioavailability. Despite inter-study heterogeneity, curcumin shows potential as an adjunctive strategy for the management of atherogenic dyslipidemia and associated metabolic disorders.<\/jats:p>","DOI":"10.3390\/nu18142279","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T08:05:31Z","timestamp":1783929931000},"page":"2279","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Curcumin in Atherogenic Dyslipidemia: Linking Preclinical Mechanistic Insights to Clinical Outcomes"],"prefix":"10.3390","volume":"18","author":[{"given":"Kamil","family":"Brodzi\u0144ski","sequence":"first","affiliation":[{"name":"Laboratory of Nutritional Biochemistry, Department of Clinical Nutrition, Medical University of Gdansk, 80-211 Gdansk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna","family":"Juszczy\u0144ska","sequence":"additional","affiliation":[{"name":"Laboratory of Nutritional Biochemistry, Department of Clinical Nutrition, Medical University of Gdansk, 80-211 Gdansk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4978-3600","authenticated-orcid":false,"given":"Joanna","family":"Karbowska","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Medical University of Gdansk, 80-211 Gdansk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0090-0725","authenticated-orcid":false,"given":"Zdzislaw","family":"Kochan","sequence":"additional","affiliation":[{"name":"Laboratory of Nutritional Biochemistry, Department of Clinical Nutrition, Medical University of Gdansk, 80-211 Gdansk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"key":"ref_1","first-page":"289","article-title":"Examen Chimique de La Racine de Curcuma","volume":"7","author":"Vogel","year":"1815","journal-title":"J. Pharm."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1002\/cber.191304602149","article-title":"Studien \u00dcber Curcumin","volume":"46","author":"Lampe","year":"1913","journal-title":"Berichte Dtsch. Chem. Ges."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.5604\/01.3001.0011.7987","article-title":"Salvia Hispanica (Chia) as a Promising Source of n-3 Polyunsaturated Fatty Acids with Antiatherogenic and Cardioprotective Properties","volume":"72","author":"Karbowska","year":"2018","journal-title":"Post\u0119py Hig. Med. Do\u015bw."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12967-020-02362-4","article-title":"Beneficial Impact of Epigallocatechingallate on LDL-C through PCSK9\/LDLR Pathway by Blocking HNF1\u03b1 and Activating FoxO3a","volume":"18","author":"Cui","year":"2020","journal-title":"J. Transl. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1186\/s40001-025-02562-y","article-title":"Quercetin Ameliorates Ox-LDL-Induced Cellular Senescence of Aortic Endothelial Cells and Macrophages by P16\/P21, P53\/SERPINE1, and AMPK\/mTOR Pathways","volume":"30","author":"Liang","year":"2025","journal-title":"Eur. J. Med. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0891-5849(03)00325-3","article-title":"Role of Phenolic O-H and Methylene Hydrogen on the Free Radical Reactions and Antioxidant Activity of Curcumin","volume":"35","author":"Priyadarsini","year":"2003","journal-title":"Free Radic. Biol. Med."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Lee, D.E., Lee, S.J., Kim, S.J., Lee, H.-S., and Kwon, O.-S. (2019). Curcumin Ameliorates Nonalcoholic Fatty Liver Disease through Inhibition of O-GlcNAcylation. Nutrients, 11.","DOI":"10.3390\/nu11112702"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Damiano, S., Longobardi, C., Andretta, E., Prisco, F., Piegari, G., Squillacioti, C., Montagnaro, S., Pagnini, F., Badino, P., and Florio, S. (2021). Antioxidative Effects of Curcumin on the Hepatotoxicity Induced by Ochratoxin A in Rats. Antioxidants, 10.","DOI":"10.3390\/antiox10010125"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.2174\/22123873MTEzBMDAb5","article-title":"Curcumin Nanomicelle Improves Lipid Profile, Stress Oxidative Factors and Inflammatory Markers in Patients Undergoing Coronary Elective Angioplasty; A Randomized Clinical Trial","volume":"21","author":"Helli","year":"2021","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"23660","DOI":"10.1038\/s41598-025-09105-9","article-title":"Curcumin Mitigates High Glucose-Induced Cardiac Oxidative Stress via Notch1 Pathway Activation","volume":"15","author":"Wu","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"7752","DOI":"10.1038\/s41598-025-91139-0","article-title":"Oxidative Stress in a Cellular Model of Alcohol-Related Liver Disease: Protection Using Curcumin Nanoformulations","volume":"15","author":"Petagine","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Salah, A., Yousef, M., Kamel, M., and Hussein, A. (2022). The Neuroprotective and Antioxidant Effects of Nanocurcumin Oral Suspension against Lipopolysaccharide-Induced Cortical Neurotoxicity in Rats. Biomedicines, 10.","DOI":"10.3390\/biomedicines10123087"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Nada, E.M., El-Gharbawy, N.M., Abbas, H., and Werida, R.H. (2025). Effect of Adding Fenofibrate versus Curcumin to Glimepiride in Patients with Type 2 Diabetes: A Randomized Controlled Trial. BMC Pharmacol. Toxicol., 26.","DOI":"10.1186\/s40360-025-00950-y"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/biof.1874","article-title":"Three Months of Combination Therapy with Nano-Curcumin Reduces the Inflammation and Lipoprotein (a) in Type 2 Diabetic Patients with Mild to Moderate Coronary Artery Disease: Evidence of a Randomized, Double-Blinded, Placebo-Controlled Clinical Trial","volume":"49","author":"Dastani","year":"2023","journal-title":"BioFactors"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2022.10.013","article-title":"Comparative Effects of Low-Dose Rosuvastatin, Placebo, and Dietary Supplements on Lipids and Inflammatory Biomarkers","volume":"81","author":"Laffin","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_18","first-page":"e2022099","article-title":"The Effects of Dietary Intervention with Turmeric on Lipid Profile and Anthropometric Indices in Overweight\/Obese Women with Hyperlipidemia: A Randomized Controlled Clinical Trial","volume":"24","author":"Atakan","year":"2022","journal-title":"Prog. Nutr."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12937-022-00816-7","article-title":"Effects of Curcumin and\/or Coenzyme Q10 Supplementation on Metabolic Control in Subjects with Metabolic Syndrome: A Randomized Clinical Trial","volume":"21","author":"Sangouni","year":"2022","journal-title":"Nutr. J."},{"key":"ref_20","first-page":"111","article-title":"How Combined and Separate Aerobic Training and Turmeric Supplementation Alter Lipid Profile and Glycemic Status? A Clinical Trial in Middle-Aged Females with Type 2 Diabetes and Hyperlipidemia","volume":"15","author":"Darmian","year":"2021","journal-title":"Int. Cardiovasc. Res. J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00394-019-01916-7","article-title":"Effects of Phytosomal Curcumin on Anthropometric Parameters, Insulin Resistance, Cortisolemia and Non-Alcoholic Fatty Liver Disease Indices: A Double-Blind, Placebo-Controlled Clinical Trial","volume":"59","author":"Cicero","year":"2020","journal-title":"Eur. J. Nutr."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.clnesp.2020.01.005","article-title":"Effects of Curcumin on Body Weight, Glycemic Control and Serum Lipids in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial","volume":"36","author":"Jamilian","year":"2020","journal-title":"Clin. Nutr. ESPEN"},{"key":"ref_23","first-page":"52","article-title":"The Effects of Nano-Curcumin Supplementation on Serum Level of Hs-CRP, Adhesion Molecules, and Lipid Profiles in Hemodialysis Patients, A Randomized Controlled Clinical Trial","volume":"14","author":"Afshar","year":"2020","journal-title":"Iran. J. Kidney Dis."},{"key":"ref_24","first-page":"e2020089","article-title":"The Effects of Curcumin Supplementation Added to Diet on Anthropometric and Biochemical Status in Women with Polycystic Ovary Syndrome: A Randomized, Placebo-Controlled Trial","volume":"22","author":"Asan","year":"2020","journal-title":"Prog. Nutr."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1002\/ptr.6312","article-title":"Effect of Turmeric on Glycemic Status, Lipid Profile, Hs-CRP, and Total Antioxidant Capacity in Hyperlipidemic Type 2 Diabetes Mellitus Patients","volume":"33","author":"Adab","year":"2019","journal-title":"Phytother. Res. PTR"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/ptr.6328","article-title":"The Effects of Curcumin Supplementation on High-Sensitivity C-Reactive Protein, Serum Adiponectin, and Lipid Profile in Patients with Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial","volume":"33","author":"Adibian","year":"2019","journal-title":"Phytother. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"102201","DOI":"10.1016\/j.ctim.2019.102201","article-title":"The Effects of Curcumin Supplementation on Glycemic Status, Lipid Profile and Hs-CRP Levels in Overweight\/Obese Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial","volume":"47","author":"Sohaei","year":"2019","journal-title":"Complement. Ther. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12944-019-0967-x","article-title":"Curcumin and\/or Omega-3 Polyunsaturated Fatty Acids Supplementation Reduces Insulin Resistance and Blood Lipids in Individuals with High Risk of Type 2 Diabetes: A Randomised Controlled Trial","volume":"18","author":"Thota","year":"2019","journal-title":"Lipids Health Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1080\/10286020.2018.1505873","article-title":"Efficacy of Phospholipidated Curcumin in Nonalcoholic Fatty Liver Disease: A Clinical Study","volume":"21","author":"Panahi","year":"2019","journal-title":"J. Asian Nat. Prod. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.metabol.2017.12.009","article-title":"Curcumin Potentiates Cholesterol-Lowering Effects of Phytosterols in Hypercholesterolaemic Individuals. A Randomised Controlled Trial","volume":"82","author":"Ferguson","year":"2018","journal-title":"Metabolism"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ctim.2017.05.006","article-title":"Curcuminoids Modify Lipid Profile in Type 2 Diabetes Mellitus: A Randomized Controlled Trial","volume":"33","author":"Panahi","year":"2017","journal-title":"Complement. Ther. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/mnfr.201501034","article-title":"Highly Bioavailable Micellar Curcuminoids Accumulate in Blood, Are Safe and Do Not Reduce Blood Lipids and Inflammation Markers in Moderately Hyperlipidemic Individuals","volume":"60","author":"Kocher","year":"2016","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/FJC.0000000000000406","article-title":"Curcumin Lowers Serum Lipids and Uric Acid in Subjects with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial","volume":"68","author":"Panahi","year":"2016","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ctim.2015.01.008","article-title":"Clinical Efficacy of the Co-Administration of Turmeric and Black Seeds (Kalongi) in Metabolic Syndrome\u2014A Double Blind Randomized Controlled Trial\u2014TAK-MetS Trial","volume":"23","author":"Amin","year":"2015","journal-title":"Complement. Ther. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"LB284","DOI":"10.1096\/fasebj.29.1_supplement.lb284","article-title":"Effect of the Complex Extracts of Lotus\/Turmeric in Accordance with Medical Nutrition Therapy in Subjects with Borderline Dyslipidemia","volume":"29","author":"Lee","year":"2015","journal-title":"FASEB J."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.ctim.2014.07.006","article-title":"Lipid-Modifying Effects of Adjunctive Therapy with Curcuminoids-Piperine Combination in Patients with Metabolic Syndrome: Results of a Randomized Controlled Trial","volume":"22","author":"Panahi","year":"2014","journal-title":"Complement. Ther. Med."},{"key":"ref_37","first-page":"201","article-title":"The Effect of Curcumin on Lipid Level in Patients with Acute Coronary Syndrome","volume":"40","author":"Alwi","year":"2008","journal-title":"Acta Medica Indones."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/07315724.2017.1358118","article-title":"A Comparative Pharmacokinetic Assessment of a Novel Highly Bioavailable Curcumin Formulation with 95% Curcumin: A Randomized, Double-Blind, Crossover Study","volume":"37","author":"Stohs","year":"2018","journal-title":"J. Am. Coll. Nutr."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/mnfr.201500681","article-title":"Redox Modulation of Curcumin Stability: Redox Active Antioxidants Increase Chemical Stability of Curcumin","volume":"60","author":"Nimiya","year":"2016","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"112575","DOI":"10.1016\/j.isci.2025.112575","article-title":"A Pharmacokinetic Study and Critical Reappraisal of Curcumin Formulations Enhancing Bioavailability","volume":"28","author":"Kroon","year":"2025","journal-title":"iScience"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/mnfr.200600283","article-title":"Glucuronidation of Curcuminoids by Human Microsomal and Recombinant UDP-Glucuronosyltransferases","volume":"51","author":"Hoehle","year":"2007","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e2100613","DOI":"10.1002\/mnfr.202100613","article-title":"Increasing Post-Digestive Solubility of Curcumin Is the Most Successful Strategy to Improve Its Oral Bioavailability: A Randomized Cross-Over Trial in Healthy Adults and In Vitro Bioaccessibility Experiments","volume":"65","author":"Flory","year":"2021","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"9721","DOI":"10.2147\/IJN.S229992","article-title":"Evaluation of Intestinal Absorption Mechanism and Pharmacokinetics of Curcumin-Loaded Galactosylated Albumin Nanoparticles","volume":"14","author":"Huang","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejpb.2017.04.004","article-title":"Transport of Curcumin Derivatives in Caco-2 Cell Monolayers","volume":"117","author":"Zeng","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_45","first-page":"105","article-title":"Metabolism of the Cancer Chemopreventive Agent Curcumin in Human and Rat Intestine","volume":"11","author":"Ireson","year":"2002","journal-title":"Cancer Epidemiol. Biomark. Prev. Publ. Am. Assoc. Cancer Res. Cosponsored Am. Soc. Prev. Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"El-Saadony, M.T., Saad, A.M., Mohammed, D.M., Alkafaas, S.S., Ghosh, S., Negm, S.H., Salem, H.M., Fahmy, M.A., Mosa, W.F.A., and Ibrahim, E.H. (2025). Curcumin, an Active Component of Turmeric: Biological Activities, Nutritional Aspects, Immunological, Bioavailability, and Human Health Benefits\u2014A Comprehensive Review. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1603018"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Girst, G., \u00d6tv\u00f6s, S.B., F\u00fcl\u00f6p, F., Balogh, G.T., and Hunyadi, A. (2021). Pharmacokinetics-Driven Evaluation of the Antioxidant Activity of Curcuminoids and Their Major Reduced Metabolites\u2014A Medicinal Chemistry Approach. Molecules, 26.","DOI":"10.3390\/molecules26123542"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez Casta\u00f1o, P., Parween, S., and Pandey, A.V. (2019). Bioactivity of Curcumin on the Cytochrome P450 Enzymes of the Steroidogenic Pathway. Int. J. Mol. Sci., 20.","DOI":"10.1101\/669440"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.bbrc.2009.08.018","article-title":"Curcumin Activates AMPK and Suppresses Gluconeogenic Gene Expression in Hepatoma Cells","volume":"388","author":"Kim","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.biopha.2018.04.143","article-title":"Dihydrocurcumin Ameliorates the Lipid Accumulation, Oxidative Stress and Insulin Resistance in Oleic Acid-Induced L02 and HepG2 Cells","volume":"103","author":"Yu","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1021\/acs.jnatprod.8b00873","article-title":"Beta-Glucuronidase Catalyzes Deconjugation and Activation of Curcumin-Glucuronide in Bone","volume":"82","author":"Kunihiro","year":"2019","journal-title":"J. Nat. Prod."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1055\/s-2006-957450","article-title":"Influence of Piperine on the Pharmacokinetics of Curcumin in Animals and Human Volunteers","volume":"64","author":"Shoba","year":"1998","journal-title":"Planta Medica"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1021\/acs.jpca.6b01434","article-title":"Quantum Chemical and Docking Insights into Bioavailability Enhancement of Curcumin by Piperine in Pepper","volume":"120","author":"Patil","year":"2016","journal-title":"J. Phys. Chem. A"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"6847","DOI":"10.1158\/1078-0432.CCR-04-0744","article-title":"Phase I Clinical Trial of Oral Curcumin: Biomarkers of Systemic Activity and Compliance","volume":"10","author":"Sharma","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1248\/bpb.34.660","article-title":"Innovative Preparation of Curcumin for Improved Oral Bioavailability","volume":"34","author":"Sasaki","year":"2011","journal-title":"Biol. Pharm. Bull."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00280-011-1749-y","article-title":"Enhancement of Curcumin Oral Absorption and Pharmacokinetics of Curcuminoids and Curcumin Metabolites in Mice","volume":"69","author":"Zhongfa","year":"2012","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/mnfr.201300724","article-title":"The Oral Bioavailability of Curcumin from Micronized Powder and Liquid Micelles Is Significantly Increased in Healthy Humans and Differs between Sexes","volume":"58","author":"Schiborr","year":"2014","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Dei Cas, M., and Ghidoni, R. (2019). Dietary Curcumin: Correlation between Bioavailability and Health Potential. Nutrients, 11.","DOI":"10.3390\/nu11092147"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Tabanelli, R., Brogi, S., and Calderone, V. (2021). Improving Curcumin Bioavailability: Current Strategies and Future Perspectives. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13101715"},{"key":"ref_60","first-page":"35","article-title":"General Principles of Pharmacokinetics","volume":"Volume 157","author":"Preskorn","year":"2004","journal-title":"Antidepressants: Past, Present and Future"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1476-511X-9-40","article-title":"Curcumin Inhibits Cholesterol Uptake in Caco-2 Cells by down-Regulation of NPC1L1 Expression","volume":"9","author":"Feng","year":"2010","journal-title":"Lipids Health Dis."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"G148","DOI":"10.1152\/ajpgi.00119.2011","article-title":"SREBP2 Mediates the Modulation of Intestinal NPC1L1 Expression by Curcumin","volume":"301","author":"Kumar","year":"2011","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/fsn3.1985","article-title":"Curcumin Inhibits the Proteolytic Process of SREBP-2 by First Inhibiting the Expression of S1P Rather than Directly Inhibiting SREBP-2 Expression","volume":"9","author":"Li","year":"2021","journal-title":"Food Sci. Nutr."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12986-025-01031-x","article-title":"Dietary Curcumin Prevents Hypercholesterolemia by Inhibiting the Transcriptional Activity of SREBP-2 and HNF1\u03b1 and Reducing Intestinal and Hepatic NPC1L1 Expression in High-Fat Diet-Fed Hamsters","volume":"22","author":"Cao","year":"2025","journal-title":"Nutr. Metab."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"109403","DOI":"10.1016\/j.jnutbio.2023.109403","article-title":"Curcumin Protects against High-Fat Diet-Induced Nonalcoholic Simple Fatty Liver by Inhibiting Intestinal and Hepatic NPC1L1 Expression via down-Regulation of SREBP-2\/HNF1\u03b1 Pathway in Hamsters","volume":"119","author":"Yang","year":"2023","journal-title":"J. Nutr. Biochem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"102549","DOI":"10.1016\/j.fbio.2023.102549","article-title":"Curcumin Alleviates Lipid Deposition in Hepatocytes through miR-3666\/AMPK Axis Regulation","volume":"53","author":"Ge","year":"2023","journal-title":"Food Biosci."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41580-022-00547-x","article-title":"New Insights into Activation and Function of the AMPK","volume":"24","author":"Steinberg","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12944-024-02162-5","article-title":"Nicotinate-Curcumin Improves NASH by Inhibiting the AKR1B10\/ACC\u03b1-Mediated Triglyceride Synthesis","volume":"23","author":"Lin","year":"2024","journal-title":"Lipids Health Dis."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"59","DOI":"10.31883\/pjfns\/182927","article-title":"Curcumin Prevents Free Fatty Acid-Induced Lipid Accumulation via Targeting the miR-22-3p\/CRLS1 Pathway in HepG2 Cells","volume":"74","author":"Mei","year":"2024","journal-title":"Pol. J. Food Nutr. Sci."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"101087","DOI":"10.1016\/j.molmet.2020.101087","article-title":"Reversal of Diet-Induced Hepatic Steatosis by Peripheral CB1 Receptor Blockade in Mice Is P53\/miRNA-22\/SIRT1\/PPAR\u03b1 Dependent","volume":"42","author":"Azar","year":"2020","journal-title":"Mol. Metab."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"12861","DOI":"10.1073\/pnas.0702509104","article-title":"Fasting-Dependent Glucose and Lipid Metabolic Response through Hepatic Sirtuin 1","volume":"104","author":"Rodgers","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.biochi.2016.12.019","article-title":"The Role and Regulation of the Peroxisome Proliferator Activated Receptor Alpha in Human Liver","volume":"136","author":"Kersten","year":"2017","journal-title":"Biochimie"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"16456","DOI":"10.1074\/jbc.M501485200","article-title":"SIRT1 Functionally Interacts with the Metabolic Regulator and Transcriptional Coactivator PGC-1\u03b1","volume":"280","author":"Nemoto","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"145642","DOI":"10.1016\/j.ijbiomac.2025.145642","article-title":"A New Target for Curcumin in the Treatment of Non-Alcoholic Fatty Liver Disease: The FTO Protein","volume":"319","author":"Fan","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_75","first-page":"277","article-title":"Diet Polyphenol Curcumin Stimulates Hepatic Fgf21 Production and Restores Its Sensitivity in High-Fat-Diet-Fed Male Mice","volume":"158","author":"Zeng","year":"2017","journal-title":"Endocrinology"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/mnfr.201100440","article-title":"Long-Term Curcumin Administration Protects against Atherosclerosis via Hepatic Regulation of Lipoprotein Cholesterol Metabolism","volume":"55","author":"Shin","year":"2011","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1074\/jbc.M107895200","article-title":"Mechanism for Fatty Acid \u201cSparing\u201d Effect on Glucose-Induced Transcription: Regulation of Carbohydrate-Responsive Element-Binding Protein by AMP-Activated Protein Kinase","volume":"277","author":"Kawaguchi","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/bcpt.12076","article-title":"Curcumin Attenuates Diet-Induced Hepatic Steatosis by Activating AMP-Activated Protein Kinase","volume":"113","author":"Um","year":"2013","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.biopha.2018.01.071","article-title":"Natural Products Berberine and Curcumin Exhibited Better Ameliorative Effects on Rats with Non-Alcohol Fatty Liver Disease than Lovastatin","volume":"99","author":"Feng","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.cmet.2011.03.009","article-title":"AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and Atherosclerosis in Diet-Induced Insulin-Resistant Mice","volume":"13","author":"Li","year":"2011","journal-title":"Cell Metab."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10616-014-9761-9","article-title":"Distinctive Pharmacological Differences between Liver Cancer Cell Lines HepG2 and Hep3B","volume":"67","author":"Qiu","year":"2015","journal-title":"Cytotechnology"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Karbowska, J., and Kochan, Z. (2025). Crosstalk Between Dietary Fatty Acids and MicroRNAs in the Regulation of Hepatic ApoB-Containing Lipoprotein Synthesis in Humans. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26104817"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"166097","DOI":"10.1016\/j.bbadis.2021.166097","article-title":"PPARs in Liver Physiology","volume":"1867","author":"Berthier","year":"2021","journal-title":"Biochim. Biophys. Acta BBA\u2014Mol. Basis Dis."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nrm4074","article-title":"Transcriptional Regulation of Hepatic Lipogenesis","volume":"16","author":"Wang","year":"2015","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1002\/mnfr.201400366","article-title":"Curcumin Enhances Cell-Surface LDLR Level and Promotes LDL Uptake through Downregulation of PCSK9 Gene Expression in HepG2 Cells","volume":"58","author":"Tai","year":"2014","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"18602","DOI":"10.1074\/jbc.M702027200","article-title":"Binding of Proprotein Convertase Subtilisin\/Kexin Type 9 to Epidermal Growth Factor-like Repeat A of Low Density Lipoprotein Receptor Decreases Receptor Recycling and Increases Degradation","volume":"282","author":"Zhang","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cell.2015.01.036","article-title":"A Century of Cholesterol and Coronaries: From Plaques to Genes to Statins","volume":"161","author":"Goldstein","year":"2015","journal-title":"Cell"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e2200139","DOI":"10.1002\/mnfr.202200139","article-title":"Micellar Curcumin: Pharmacokinetics and Effects on Inflammation Markers and PCSK-9 Concentrations in Healthy Subjects in a Double-Blind, Randomized, Active-Controlled, Crossover Trial","volume":"66","author":"Grafeneder","year":"2022","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_89","unstructured":"U.S. Food and Drug Administration (FDA) (2026, March 23). Curcumin from Turmeric (Curcuma longa L.)\u2014GRAS Notice No. GRN 686, Available online: https:\/\/hfpappexternal.fda.gov\/scripts\/fdcc\/index.cfm?id=686&set=GRASNotices."},{"key":"ref_90","unstructured":"World Health Organization (WHO) (2026, March 24). Curcumin (INS No. 100(i))\u2014JECFA Monographs and Evaluations. Available online: https:\/\/apps.who.int\/food-additives-contaminants-jecfa-database\/Home\/Chemical\/1355."},{"key":"ref_91","unstructured":"(2010). EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS). Scientific Opinion on the Re-evaluation of Curcumin (E 100) as a Food Additive. EFSA J., 8, 1679."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Lao, C.D., Ruffin, M.T., Normolle, D., Heath, D.D., Murray, S.I., Bailey, J.M., Boggs, M.E., Crowell, J., Rock, C.L., and Brenner, D.E. (2006). Dose Escalation of a Curcuminoid Formulation. BMC Complement. Altern. Med., 6.","DOI":"10.1186\/1472-6882-6-10"},{"key":"ref_93","first-page":"6029403","article-title":"Drug Induced Liver Injury Attributed to a Curcumin Supplement","volume":"2019","author":"Imam","year":"2019","journal-title":"Case Rep. Gastrointest. Med."},{"key":"ref_94","first-page":"e3858","article-title":"Iron Deficiency Anemia Due to High-Dose Turmeric","volume":"11","author":"Smith","year":"2019","journal-title":"Cureus"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40780-017-0083-x","article-title":"Effect of Health Foods on Cytochrome P450-Mediated Drug Metabolism","volume":"3","author":"Sasaki","year":"2017","journal-title":"J. Pharm. Health Care Sci."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"174906","DOI":"10.1016\/j.ejphar.2022.174906","article-title":"Molecular Targets of Statins and Their Potential Side Effects: Not All the Glitter Is Gold","volume":"922","author":"Patel","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"ref_97","unstructured":"(2026, February 24). UniProt CYP1A2 Cytochrome P450 1A2. Available online: https:\/\/www.uniprot.org\/uniprotkb\/P05177\/entry."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1124\/dmd.108.020552","article-title":"Curcuminoids Inhibit Multiple Human Cytochromes P450, UDP-Glucuronosyltransferase, and Sulfotransferase Enzymes, Whereas Piperine Is a Relatively Selective CYP3A4 Inhibitor","volume":"36","author":"Volak","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"ref_99","unstructured":"(2026, February 24). UniProt CYP2B6 Cytochrome P450 2B6. Available online: https:\/\/www.uniprot.org\/uniprotkb\/P20813\/entry#expression."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Daly, A.K., Rettie, A.E., Fowler, D.M., and Miners, J.O. (2017). Pharmacogenomics of CYP2C9: Functional and Clinical Considerations. J. Pers. Med., 8.","DOI":"10.3390\/jpm8010001"},{"key":"ref_101","unstructured":"(2026, February 24). UniProt CYP2C9 Cytochrome P450 2C9. Available online: https:\/\/www.uniprot.org\/uniprotkb\/P11712\/entry."},{"key":"ref_102","unstructured":"Kane, M. (2025). CYP2D6 Overview: Allele and Phenotype Frequencies. Medical Genetics Summaries [Internet], National Center for Biotechnology Information (US)."},{"key":"ref_103","unstructured":"(2026, February 24). UniProt CYP2D6 Cytochrome P450 2D6. Available online: https:\/\/www.uniprot.org\/uniprotkb\/P10635\/entry."},{"key":"ref_104","unstructured":"(2026, February 24). UniProt CYP3A4 Cytochrome P450 3A4. Available online: https:\/\/www.uniprot.org\/uniprotkb\/P08684\/entry."},{"key":"ref_105","unstructured":"(2026, February 25). UniProt CYP17A1 Steroid 17-Alpha-Hydroxylase\/17,20 Lyase. Available online: https:\/\/www.uniprot.org\/uniprotkb\/P05093\/entry."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"110573","DOI":"10.1016\/j.abb.2025.110573","article-title":"Molecular Insights into CYP19A1 Mutations and Their Role in Estrogen Production","volume":"772","author":"Lee","year":"2025","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_107","unstructured":"(2026, February 25). UniProt CYP19A1 Aromatase. Available online: https:\/\/www.uniprot.org\/uniprotkb\/P11511\/entry."},{"key":"ref_108","unstructured":"(2026, February 25). UniProt CYP21A2 Steroid 21-Hydroxylase. Available online: https:\/\/www.uniprot.org\/uniprotkb\/P08686\/entry."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/18\/14\/2279\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:07:24Z","timestamp":1784545644000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/18\/14\/2279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":108,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["nu18142279"],"URL":"https:\/\/doi.org\/10.3390\/nu18142279","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]}}}